Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KDM6B | O15054 | 1/20 | 0.33 |
| ▸ | KDM5C | P41229 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29195613 | 1.00 | ALDH1A1 (0.62) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL28289780 | 0.97 | ALDH1A1 (0.59) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL11908325 | 0.92 | ALDH1A1 (0.55) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL5273856 | 0.88 | ALDH1A1 (0.56) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL11591970 | 0.86 | ALDH1A1 (0.53) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL27851638 | 0.86 | ALDH1A1 (0.53) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL27970775 | 0.86 | ALDH1A1 (0.53) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL3555482 | 0.85 | ALDH1A1 (0.46) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL11020511 | 0.84 | ALDH1A1 (0.50) | ALDH1A1LMNASLC15A2TSHRTDP1 | |
| SCHEMBL28749707 | 0.84 | ALDH1A1 (0.50) | ALDH1A1LMNASLC15A2TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112745372-B | Functional saccharide molecule based on TDG molecular skeleton and preparation method thereof | 深圳先进技术研究院 | 2022-07-12 | — | — | CN | claimed |
| CN-113801630-A | Biomass-mineral composite material and preparation method thereof | 俏东方生物燃料集团有限公司 | 2021-12-17 | — | — | CN | claimed |
| CN-112832022-A | Preparation method of ultraviolet-proof shirt, T-shirt and fabric based on carboxylic anhydride | 浙江科峰有机硅有限公司 | 2021-05-25 | — | — | CN | claimed |
| WO-2021081881-A1 | FUNCTIONAL CARBOHYDRATE MOLECULE BASED ON TDG MOLECULAR SCAFFOLD, AND PREPARATION METHOD THEREFOR | 深圳先进技术研究院 | 2021-05-06 | — | — | WO | claimed |
| CN-112745372-A | Functional saccharide molecule based on TDG molecular skeleton and preparation method thereof | 深圳先进技术研究院 | 2021-05-04 | — | — | CN | claimed |
| CN-107118190-B | A kind of preparation method and application of the fluorescence chemical sensing material based on coumarin derivative | 江苏大学 | 2019-06-28 | — | — | CN | claimed |
| CN-107118190-A | A kind of preparation method of fluorescence chemical sensing material based on coumarin derivative and application | 江苏大学 | 2017-09-01 | — | — | CN | claimed |
| WO-2015026234-A1 | SUPPORTED METAL NANOPARTICLE-BASED CATALYST FOR THE HYDROGENATION OF A LEVULINIC ACID SOURCE | UNIVERSITEIT UTRECHT HOLDING B.V. (NL) | 2015-02-26 | — | — | WO | claimed |
| CN-103497224-A | Preparation method of 3-O-benzyl-1,2-O-isopropylidene-4-acetyl propionyl-Beta-L-iduronate furanose aldehyde acid methyl ester | CARBOTANG BIOTECH CO LTD | 2014-01-08 | — | — | CN | claimed |
| CN-102898487-A | Fondaparinux sodium disaccharide intermediate fragment BA and synthetic method thereof | MCCULL PHARMA NANTONG INC | 2013-01-30 | — | — | CN | claimed |
| US-20070172925-A1 | Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound | NIPPON SHINYAKU CO., LTD. (JP) | 2007-07-26 | — | — | US | claimed |
| CN-1910193-A | Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound | NIPPON SHINYAKU CO LTD (JP) | 2007-02-07 | — | — | CN | claimed |
| EP-1710249-A1 | RIBONUCLEIC ACID COMPOUND AND METHOD OF LIQUID-PHASE SYNTHESIS OF OLIGONUCLEIC ACID COMPOUND | Nippon Shinyaku Co., Ltd. (JP) | 2006-10-11 | — | — | EP | claimed |
| US-4471113-A | ANTICARCINOGENIC AGENT, VERICIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF ENERGY (US) | 1984-09-11 | — | — | US | claimed |
| EP-3474890-B1 | PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | MAX PLANCK GESELLSCHAFT (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4727929-A2 | 5'-MODIFIED MONOMERS, OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS | Alnylam Pharmaceuticals, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250057867-A1 | NUCLEOSIDE PHOSPHORAMIDATES | GILEAD SCIENCES INC (US) | 2025-02-20 | — | — | US | disclosed |
| US-4365086-A | CURING AGENTS FOR THERMOPLASTIC ELASTOMERS | PENNWALT CORPORATION (US) | 1982-12-21 | — | — | US | disclosed |
| US-4328360-A | VULCANIZING AGENT FOR THERMOPLASTIC RESINS | PENNWALT CORPORATION (US) | 1982-05-04 | — | — | US | disclosed |
| US-4052543-A | VULCANIZABLE AND VULCANIZED COMPOSITIONS CONTAINING POLYPEROXIDE | PENNWALT CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057867-A1 | NUCLEOSIDE PHOSPHORAMIDATES | PNP, RNGTT, NSUN2 | ALDH1A1 3204/4885LMNA 4349/4885SLC15A2 2570/4885 |
| US-20070172925-A1 | Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound | RNASEH1, NSUN2, POLR2H | ALDH1A1 1308/4885LMNA 648/4885SLC15A2 3948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.